Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Issues Health Notice for Transvaginal Placement of Surgical Mesh - Medical Product Outsourcing

FDA Issues Health Notice for Transvaginal Placement of Surgical Mesh

Nine manufacturers report erosion of device in patients

The FDA put out a public health notice concerning complications associated with the transvaginal placement of surgical mesh to treat pelvic organ prolapse and stress urinary incontinence.

The agency received reports from nine surgical mesh manufacturers who said patients had experienced erosion through the vagina, infection, pain, urinary problems and recurrence of prolapse or incontinence. There also were reports of bowel, bladder and blood vessel perforation during insertion, the FDA said.

“[The] FDA has received reports of complications associated with the placement of mesh through an incision made in the wall of the vagina,” the notice stated. “Although rare, these complications can have serious consequences. The reports have not been linked to a single brand or model of mesh.”

In some cases, the notice added, erosion of the mesh and scarring of the vagina led to discomfort and pain. Some patients needed additional surgery to remove the mesh that had eroded into the vagina.

SOURCE: FDANEWS


Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters